Jasper Therapeutics, Inc. is a biotechnology company focused on hematopoietic cell transplant therapies. The Company has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent t... اقرأ أكثر
احصل على تحليلات مفصلة للأسهم من LSEG تتضمن السعر المستهدف بحسب رأي المحللين.